Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Greystone Housing Impact Investors LP Schedules Fourth Quarter 2025 Earnings Conference Call and Issues Investor Schedule K-1s
-
Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting
-
Mr. Rooter Plumbing of North Miami Beach Surpasses 100 Google Reviews with 5-Star Rating
-
Greystone Provides $46 Million Bridge-to-HUD Loan for Seniors Housing Portfolio in Ohio
-
Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026
-
Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial
-
Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival
-
Adagene’s Muzastotug (ADG126) to be Highlighted in Two Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA
-
Sportradar to Participate in the 38th Annual Roth Conference
-
Prelude Therapeutics Announces Acceptance of Preclinical Abstract for PRT13722, a First-in-Class Oral KAT6A Selective Degrader at the 2026 AACR Annual Meeting
-
Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026
-
SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference
-
Department of Energy Mandates Centralia Unit 2 Remain Available for Operation for Additional 90 Days
-
TransAlta Corporation Announces Conversion Results for Series A and B Preferred Shares
-
BlossomHill Therapeutics Unveils New Pan-KRAS Inhibitor Programs and Announces Upcoming Presentations at AACR Annual Meeting 2026
-
Molecular Partners to Hold Three Poster Presentations at AACR 2026
-
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Akari Therapeutics Announces ADS Ratio Change
-
Parsons Announces New Chief Human Resources Officer
-
UMH PROPERTIES, INC. PUBLISHES ITS 2025 ANNUAL REPORT
-
Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
-
Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum
-
Enara Bio to Unveil First‑in‑Class DARKFOX‑Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential for Solid Tumor Immunotherapy
-
Evaxion to present new data at AACR Annual Meeting
-
Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting
-
NNIT A/S: New CEO to lead NNIT into its next phase of growth
-
Super League Sets Fourth Quarter and Full Year 2025 Earnings Date, March 27, 2026
-
Fold Holdings, Inc. (NASDAQ: FLD) Announces Fourth Quarter and Full Year 2025 Results
-
Ocean Power Technologies, Inc. Announces Third Quarter Fiscal 2026 Results
-
Sportsman's Warehouse Holdings, Inc. Schedules Fourth Quarter and Full-Year 2025 Earnings Conference Call
-
Waterstone Financial Raises Quarterly Cash Dividend by 13.3%
-
Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates
-
Longeveron Announces 2025 Full Year Financial Results and Provides Business Update
-
Dave & Buster’s Entertainment, Inc. to Report Fourth Quarter and Fiscal Year End 2025 Financial Results on March 31, 2026
-
Orion Group Holdings, Inc. Announces Retirement of Two Board Members and Decrease in Board Size
-
Cibus Reports Fourth Quarter Financial Results and Provides Business Update
-
American Coastal Insurance Corporation Announces the Completion of $5 Million in Common Stock Share Repurchases
-
Comscore Reports Fourth Quarter and Full Year 2025 Results
-
Synergy CHC Corp. Announces Fourth Quarter and Full Year 2025 Earnings and Conference Call Information
-
HF Foods to Participate in the 38th Annual Roth Conference
-
Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer
-
Euroseas Ltd. Announces Order for the Construction of Two 2,800 TEU, High-Reefer Containerships
-
Ormat Technologies, Inc. Announces Proposed Offering of $600 Million of Series A Convertible Senior Notes and $150 Million of Series B Convertible Senior Notes
-
Canadian Net REIT Announces 2025 Fourth-Quarter Results
-
Trisura to Participate in National Bank Financial Services Conference
-
HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook
-
IZEA Achieves Record $18.9M Profitability Swing, Breaking Even on $31.2M of Revenue
-
Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results
-
SAB BIO Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
Royalty Pharma Announces Expansion of Leadership Team

